What is the current valuation of the US healthcare biometrics market?

The market valuation was $8.5 Billion in 2024. Read More

What is the projected market size for the US healthcare biometrics market by 2035?

The market is projected to reach $75.0 Billion by 2035. Read More

What is the expected CAGR for the US healthcare biometrics market during the forecast period 2025 - 2035?

The expected CAGR is 21.89% during the forecast period. Read More

Which technology segment is expected to dominate the US healthcare biometrics market?

Facial Recognition is expected to dominate, with a projected valuation of $20.0 Billion by 2035. Read More

What are the key applications driving growth in the US healthcare biometrics market?

Patient Identification and Telemedicine are key applications, projected at $22.5 Billion and $19.5 Billion respectively by 2035. Read More

Which deployment model is anticipated to have the highest market share in the US healthcare biometrics market?

The Cloud-Based deployment model is anticipated to have the highest share, projected at $36.0 Billion by 2035. Read More

Who are the leading players in the US healthcare biometrics market?

Key players include Cerner Corporation, Philips Healthcare, Siemens Healthineers, and GE Healthcare. Read More

What is the projected market size for hospitals using healthcare biometrics by 2035?

The projected market size for hospitals is $22.5 Billion by 2035. Read More

How does the market for voice recognition technology in healthcare biometrics compare to others?

Voice Recognition is projected at $10.0 Billion by 2035, indicating substantial growth but less than Facial Recognition. Read More

What is the expected growth trajectory for clinics utilizing healthcare biometrics?

The market for clinics is projected to reach $15.0 Billion by 2035, reflecting a robust growth trajectory. Read More

US Healthcare Biometrics Market

ID: MRFR/HCIT/17127-HCR

100 Pages

Nidhi Mandole

Last Updated: April 06, 2026

US Healthcare Biometrics Market Research Report: Size, Share, Trend Analysis By Technology (Fingerprint Recognition, Iris Recognition, Facial Recognition, Voice Recognition, Vein Recognition), By Applications (Patient Identification, Access Control, Billing and Payments, Electronic Health Records, Telemedicine), By End Use (Hospitals, Clinics, Diagnostic Centers, Pharmaceutical Companies, Research Institutions) and By Deployment (On-Premise, Cloud-Based, Hybrid) - Growth Outlook & Industry Forecast 2025 To 2035

US Healthcare Biometrics Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Technology (USD Billion)
  1. 4.1.1 Fingerprint Recognition
  2. 4.1.2 Iris Recognition
  3. 4.1.3 Facial Recognition
  4. 4.1.4 Voice Recognition
  5. 4.1.5 Vein Recognition
2. 4.2 Pharmaceutical, BY Application (USD Billion)
  1. 4.2.1 Patient Identification
  2. 4.2.2 Access Control
  3. 4.2.3 Billing and Payments
  4. 4.2.4 Electronic Health Records
  5. 4.2.5 Telemedicine
3. 4.3 Pharmaceutical, BY Use (USD Billion)
  1. 4.3.1 Hospitals
  2. 4.3.2 Clinics
  3. 4.3.3 Diagnostic Centers
  4. 4.3.4 Pharmaceutical Companies
  5. 4.3.5 Research Institutions
4. 4.4 Pharmaceutical, BY Deployment (USD Billion)
  1. 4.4.1 On-Premise
  2. 4.4.2 Cloud-Based
  3. 4.4.3 Hybrid
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Cerner Corporation (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Philips Healthcare (NL)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Siemens Healthineers (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 GE Healthcare (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Medtronic (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Honeywell (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 3M Company (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Fujitsu (JP)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 NantHealth (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
  10. 5.2.10 NextGen Healthcare (US)
    1. 5.2.10.1 Financial Overview
    2. 5.2.10.2 Products Offered
    3. 5.2.10.3 Key Developments
    4. 5.2.10.4 SWOT Analysis
    5. 5.2.10.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TECHNOLOGY
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY USE
5. 6.5 US MARKET ANALYSIS BY DEPLOYMENT
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
14. 6.14 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Billion)
16. 6.16 PHARMACEUTICAL, BY USE, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY USE, 2024 TO 2035 (USD Billion)
18. 6.18 PHARMACEUTICAL, BY DEPLOYMENT, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY DEPLOYMENT, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY USE, 2025-2035 (USD Billion)
  4. 7.2.4 BY DEPLOYMENT, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pharmaceutical Market Segmentation

Pharmaceutical By Technology (USD Billion, 2025-2035)

Fingerprint Recognition
Iris Recognition
Facial Recognition
Voice Recognition
Vein Recognition

Pharmaceutical By Application (USD Billion, 2025-2035)

Patient Identification
Access Control
Billing and Payments
Electronic Health Records
Telemedicine

Pharmaceutical By Use (USD Billion, 2025-2035)

Hospitals
Clinics
Diagnostic Centers
Pharmaceutical Companies
Research Institutions

Pharmaceutical By Deployment (USD Billion, 2025-2035)

On-Premise
Cloud-Based
Hybrid

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”